Hmmm good point regarding the reimbursement. So I suppose a doctor/family's decision with which drug to run with may came down to efficacy and/or adverse effects in the event that both drugs are brought to market.
Let's hope the P2 results for 2591 in PWS show results as significant, and adverse effects so minimal, as they did with PMS. My money (quite literally) says they will.
GLA.
PHASE2 PRADER WILLI SYNDROME START !!!!, page-33
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.68 |
Change
-0.100(0.48%) |
Mkt cap ! $2.643B | |||
| Open | High | Low | Value | Volume |
| $20.50 | $20.74 | $20.01 | $5.091M | 247.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 156 | $20.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.68 | 256 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |